1 Day
Source:
The Boston Globe
Biotech Recovery Boosted by Deals
The article focuses on the resurgence of Boston’s biotech industry, driven by a wave of high-value mergers and acquisitions. After a slowdown during the pandemic, deal activity has surged, with over $85 billion in large deals announced globally in the first half of 2026, surpassing last year's totals. This renewed M&A momentum is attracting major pharma companies, addressing patent expiries, and increasing local industry activity, which is expected to generate jobs and reduce lab vacancies over time.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)